and quadrupolar coupling (QC) tensors were measured for the carboxylate groups in these two compounds. With the aid of plane wave DFT computations, the 17 O CS and QC tensor orientations were determined in the molecular frame of reference. Significant changes in the 17 O CS and QC tensors were observed for the carboxylate oxygen atom upon its coordination to Pt(II). In particular, the 17 O isotropic chemical shifts for the oxygen atoms directly bonded to Pt(II) are found to be smaller (more shielded) by 200 ppm than those for the non-Pt-coordinated oxygen atoms within the same carboxylate group. Examination of the 17 O CS tensor components reveals that such a large 17 O coordination shift is primarily due to the shielding increase along the direction that is within the O=C-O-Pt plane and perpendicular to the O-Pt bond. This result is interpreted as due to the donation from the oxygen nonbonding orbital (electron lone pair) to the Pt(II) empty d yz orbital, which results in large energy gaps between (Pt-O) and unoccupied molecular orbitals, thus reducing the paramagnetic shielding contribution along the direction perpendicular to the O-Pt bond. We found that the 17 O QC tensor of the carboxylate oxygen is also sensitive to Pt(II) coordination, and that 17 O CS and QC tensors provide complementary information about the O-Pt bonding.
Introduction
In recent years, solid-state 17 O NMR spectroscopy has been shown to be a useful technique for direct detection and characterization of oxygen nuclei in organic and biological molecules. [1] [2] [3] [4] The remarkable sensitivity of 17 O quadrupolar coupling (QC) and chemical shift (CS) tensors toward molecular interactions such as hydrogen bonding and metal-ligand interactions makes 17 O an important NMR probe, capable of providing information that sometimes is difficult to obtain with the more conventional 1 H, 13 C, and 15 N NMR studies. Over the past decade, 17 O QC and CS tensors have been experimentally determined for many oxygen-containing organic functional groups. At the present time the solid-state 17 O NMR method finds its use not only for studying protein-ligand complexes, 5 but also for obtaining dynamic information about molecular motions in organic solids. 6 The most recent advances in solid-state 17 O NMR include studies of pharmaceuticals 7, 8 and paramagnetic coordination compounds. 9 Another significant recent development is the application of dynamic nuclear polarization (DNP) to drastically boost the sensitivity of solid-state 17 O NMR experiments. [10] [11] [12] In the present work, we use solid-state 17 O NMR to study two platinum anticancer drugs: carboplatin and oxaliplatin (Scheme 1). Although several thousand platinum-based anticancer drug molecules have been developed in research laboratories over the past 30 years, only about two dozen have ever gone into clinical trials. Carboplatin and oxaliplatin are the only two Pt compounds that have gained international marketing approval. 13 Both carboplatin and oxaliplatin show significantly less toxicity than cisplatin, the first commercial platinum-based drug. While both solution and solid-state NMR techniques utilizing 1 H, 13 C, 14/15 N, 195 Pt, and 35 Cl as nuclear probes have been extensively employed to study Pt anticancer drugs, 14-19 17 O NMR has not yet been explored in the studies of this class of drug molecules.
In carboplatin and oxaliplatin, the mode of bonding between the carboxylate group and the Pt(II) metal center can be described as being monodentate, O=C-O-Pt(II), where the 4 atoms are essentially in the same plane. While there have been a number of experimental solid-state 17 O NMR and computational studies on the 17 O QC and CS tensors in carboxylic acids and their salts, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] none of the previous studies have dealt with a carboxylate (-COO − ) group bound to Pt(II). The primary goals of the present study are (i) to experimentally determine the 17 O CS and QC tensors in these important Pt(II) anticancer drugs and (ii) to examine the effect of bonding to a transition metal on these 17 O NMR tensors. In carboplatin and oxaliplatin, since the mode of bonding is O=C-O-Pt(II), the non-Pt-coordinated oxygen atom can serve as an internal reference, making it easier to examine the effect of metal binding on 17 O NMR tensors. Another reason for us to choose these two platinum anticancer drugs is that their crystal structures have been reported. 36, 37 The known crystal structures would allow us to perform plane wave DFT calculations of the 17 O NMR tensors in these compounds. These calculations have been proven to produce reliable tensor orientations in the molecular frame of reference and thus can aid the interpretation of the experimental data. 38, 39 with necessary modifications for 17 O isotopic incorporation. Schematic diagrams illustrating the employed synthetic strategies are given in the Supplementary data, and the synthetic details are described below.
Experimental section

Dipotassium 1,1-cyclobutane-[ 17 O 4 ]-dicarboxylate
1,1-Cyclobutanedicarboxylic acid (300 mg) was dissolved in 40% 17 O-enriched water (310 L, purchased from CortecNet) and heated at 80°C for 22 h. After cooling to room temperature (RT), the solution was neutralized by addition of a solution of KOH (233 mg) in EtOH (8 mL). After the mixture was left in a refrigerator for 20 min, the white solid was collected by filtration, washed with EtOH (3 × 3 mL), and then dried under vacuum. A total of 366 mg of the title compound were obtained.
[ 17 O 4 ]Carboplatin
cis-Diaminodiiodoplatinum(II) (567 mg, 1.17 mmol) and AgNO 3 (400 mg, 2.34 mmol) were added to H 2 O (30 mL), and the solution was stirred in an oil bath at 45-50°C (under darkness) for 3 h. After cooling to RT, the insoluble material was removed by filtration through a pad of Celite. The filter pad was washed with H 2 O (5 mL). The filtrate and washing were combined in a flask containing dipotassium 1,1-cyclobutane-[ 17 O 4 ]-dicarboxylate (244 mg, 1.10 mmol), forming a clear solution. The mixture was concentrated to dryness on a rotary evaporator at 55°C. The residual material was treated in H 2 O (5 mL) followed by addition of 2 drops of 30% ammonium hydroxide solution. The mixture was heated briefly to dissolve most of the solid and filtered (a small amount of yellowish insoluble material was thus removed), and the filtrate was concentrated to dryness. The residual material was treated with H 2 O (1 mL), heated briefly, then cooled to 4°C. The solid material was collected, washed with cold H 2 O (2 × 0.5 mL) and ethanol (0.5 mL), and dried under vacuum. The title compound was obtained as a white, free-flow crystalline solid (220 mg, yield 54%). 1 17 O-enriched water (1 mL) and 1,4-dioxane (10 mL) at 60°C for 66 h. After the solvent was recovered with an N 2 flow passing through the flask into a cold trap, 2.3 g of solid was obtained (46% of the mass was residual solvent). This solid material was then added to a solution of KOH (2.0 g) in water (10 mL). The solution was concentrated (rotary evaporation at <50°C) to a solid residue, which was further treated with EtOH (25 mL). The white solid was collected by filtration and washed with EtOH (3 × 10 mL). After drying the solid, a total of 2.3 g of the title compound were obtained.
[ 17 O 4 ]Oxaliplatin
Dichloro(R,R-cyclohexane-1,2-diamine)platinum(II) (540 mg, 1.42 mmol) and AgNO 3 (460 mg, 2.70 mmol) were added to 30 mL of H 2 O. In the dark, the mixture was stirred in an oil bath at 90°C for 5 min, and then cooled for over 1 h to RT. The mixture was stirred at RT overnight. Insoluble material was removed by filtration through a pad of Celite, and then the pad was washed with H 2 O (5 mL). The filtrate was collected in a 100 mL flask, to which dipotassium [ 17 O 4 ] oxalate (220 mg, 1.32 mmol) was then added. The mixture was concentrated to dryness on a rotary evaporator at 35-40°C. The residual material was treated with H 2 O (5 mL). The solid material was collected by filtration and washed with cold H 2 O (4 × 3 mL, and 2 × 4 mL). After drying the solid under vacuum, the title compound was obtained as a white powder (285 mg, yield 54%). 1 
Solid-state 17 O NMR
Solid-state 17 O NMR experiments were performed on Bruker Avance-600 (14.1 T) and Bruker Avance-II 900 (21.1 T) NMR spectrometers. A Hahn-echo sequence was used for both static and magicangle spinning (MAS) experiments to eliminate the acoustic ringing from the probe. Effective 90°pulses of 1.7 and 1.0 s were used for the 17 and MAS spectra. For oxaliplatin at 21.1 T, the recycle delay was 60 s for both static and MAS spectra. A total of 896 transients and 1500 transients were accumulated in the static and MAS experiments, respectively. For carboplatin at 14.1 T, the recycle delay was 5 s for collecting both static (8348 transients) and MAS Table 1 were used to simulate the spectra recorded at two magnetic fields. Note that the spinning sidebands are clearly visible in the simulated spectra at 14.1 T. Other data acquisition parameters are given in the text. 
Computational details
Plane wave pseudopotential DFT calculations of the NMR shielding and electric field gradient parameters were performed using the Cambridge Serial Total Energy Package (CASTEP) software and Materials Studio 4.4 program (Accelrys) 41, 42 on a HP xw4400 workstation with a single Intel Dual-Core 2.67 GHz processor and 8 GB DDR RAM. The Perdew, Burke, and Ernzerhof (PBE) functionals was used in all calculations in the generalized gradient approximation (GGA) for the exchange correlation energy. 43, 44 On-the-fly pseudopotentials were used as supplied with NMR CASTEP with a plane wave basis set cut-off energy of 550 eV, and the Monkhorst-Pack k-space grid sizes of 3 × 2 × 2 (2 k-points used) and 2 × 3 × 3 (9 k-points used) for carboplatin and oxaliplatin, respectively. The reported crystal structures of carboplatin 36 and oxaliplatin 37 were used as starting structures, and then geometry optimization was performed using the BFGS method 45 without the cell optimization. The following convergence tolerance parameters were used in the geometry optimization process: total energy 5 × 10 −5 eV/atom, maximum displacement 0.005 Å, maximum force 0.1 eV/Å, and maximum stress 0.2 GPa. Nuclear magnetic shielding calculations were also performed with the Amsterdam Density Functional (ADF, version 2012) 46 software package. VoskoWilk-Nusair (VWN) exchange-correlation functional 47 was used for the local density approximation (LDA), and the PBE exchangecorrelation functionals 43, 44 was applied for the generalized gradient approximation (GGA). Standard Slater-type orbital (STO) basis sets with triple-zeta quality plus polarization functions (TZ2P) were used for all the atoms. The spin orbital relativistic effect was incorporated via the zero-order regular approximation (ZORA). [48] [49] [50] [51] The ADF calculations were carried out on Sun SPARC Enterprise M9000 servers at the High Performance Computing Virtual Laboratory (HPCVL) of Queen's University. Each of the servers consists of 64 quad-core 2.52 GHz sparc64 VII processors with 8 GB of RAM per core (2 TB of total memory).
Results and discussion
Experimental determination of 17 O NMR tensors
The general solid-state NMR approach for the experimental characterization of 17 O CS and QC tensors consists of two steps. First, one obtains good-quality 17 O NMR spectra under the MAS condition, from which the values of ␦ iso , C Q , and Q can be obtained for each oxygen site. Second, one records 17 O static NMR spectra preferably at multiple magnetic fields. An analysis of the static spectra would allow determination of the 17 O CS tensor components (␦ 11 , ␦ 22 , ␦ 33 ) and their relative orientations with respect to the QC tensor. A detailed theoretical background can be found in the literature. 52, 53 Figure 1 shows the 17 ]oxaliplatin at two magnetic fields. In each MAS spectrum, two groups of signals were observed, corresponding to the two types of oxygen atoms (directly Pt-bonded and non-Pt-coordinated) in carboplatin and oxaliplatin. At 14.1 T, since the sample spinning frequency was only 14.5 kHz, weak spinning sidebands are visible for each central band from the simulated spectra. As these weak spinning sidebands happen to overlap with the central bands, they somewhat obscure the fine spectral features. At 21.1 T, in contrast, the sample spinning frequency was 50 kHz, and the MAS spectra, now free of spinning sidebands, exhibit very high spectral resolutions. It is interesting to note that while two oxygen sites are observed for carboplatin, a total of 4 oxygen sites (2 pairs) are detected for oxaliplatin. The crystal structure of carboplatin 36 indicates the presence of a mirror plane that contains the Pt(II) center and the average cyclobutane ring bisecting the molecule. As a result, the two carboxylate groups in carboplatin are symmetry related. In comparison, the crystal structure of oxaliplatin 37 suggests that all 4 oxygen atoms of the oxalate group are crystallographically distinct. Therefore, the solid-state 17 O NMR observations shown in Fig. 1 are in agreement with the crystal structures of these compounds. As also seen from Fig. 1 , experimental MAS spectra recorded at two magnetic fields for the same compound are matched very well by the simulated ones using the same set of NMR parameters. The experimental values of ␦ iso , C Q , and Q are summarized in Table 1 . In general, carboplatin and oxaliplatin exhibit similar 17 O NMR parameters. The most interesting finding is that the 17 O chemical shifts for the oxygen atoms directly bonded to Pt(II) and the non-Pt-coordinated oxygen atoms differ by 200 ppm (vide infra); also see the solution 17 O spectra of these compounds in the Supplementary data. The directly Pt-bonded oxygens exhibit smaller C Q values (ca. |C Q | ≈ 6 MHz) than do the non-coordinated oxygens (|C Q | ≈ 8 MHz), in agreement with previous observations on the effect from metalligand interactions. 54 It is important to note that the sign of C Q cannot be readily determined simply from MAS and static spectra. Figure 2 shows the 17 O static NMR spectra of carboplatin and oxaliplatin recorded at 21.1 T. Similarly, the static spectra were Table 1 . The corresponding static spectra recorded at 14.1 T together with spectral simulations are provided in the Supplementary data. also obtained at 14.1 T (shown in the Supplementary data). Because of the low resolution in the static spectra, it was not possible to treat all 4 crystallographically distinct oxygen sites in oxaliplatin individually. Thus we assumed only 2 CS tensors (O1/O2 and O3/ O4) in the spectral simulation. As seen from Fig. 2 , the general agreement between experimental and simulated static spectra is satisfactory. Again, all experimental 17 O CS tensor components for carboplatin and oxaliplatin are listed in Table 1 .
Plane wave DFT calculations and the tensor orientations
As the crystal structures for carboplatin and oxaliplatin are known, we performed plane wave DFT calculations using the CASTEP program. 41, 42 This approach will produce results that can be directly compared with solid-state NMR data without any assumption on the size of the molecular cluster. The CASTEP results for 17 O NMR tensors are summarized in Table 1 . In general, the computational results are in good agreement with the experimental data. A correlation plot (slope = 0.964; R 2 = 0.988) between experimental and computed 17 O CS tensor components is given in the Supplementary data. We should point out that the agreement between calculated and experimental results is clearly better for the non-Pt-coordinated oxygen atoms than for the directly Pt-coordinated ones, which is likely due to the neglect of relativistic effects in the CASTEP calculations. The computations also reveal a sign change in C Q between the 2 types of oxygen atoms. For the non-Pt-coordinated oxygen atom, C Q is positive, and it becomes negative for the directly Pt-bonded oxygen (vide infra).
Another benefit of the CASTEP calculations is that the 17 O CS and QC tensor orientations can be unambiguously determined in the molecular frame of reference. As we have shown previously, 52, [54] [55] [56] [57] the absolute orientations of the 17 O NMR tensors in the molecular frame of reference can be reliably predicted by modern quantum chemical calculations. The CASTEP results for the tensor orientations in carboplatin and oxaliplatin are depicted in Fig. 3 .
For the non-Pt-coordinated oxygen atom, zz and yy both lie in the O=C-O plane, being perpendicular to and along the C=O bond, respectively. This makes xx perpendicular to the O=C-O plane. This 17 O QC tensor orientation is typical of a carbonyl functional group. The 17 O QC tensor orientation is quite different for the chelating oxygen, for which the zz component is in plane but essentially along the C-O bond. The 17 O CS tensors are also quite different for the two types of oxygen atoms. For the directly Ptbonded oxygen atom, ␦ 11 of the 17 O CS tensor is oriented along the O-Pt bond, which makes it nearly perpendicular to the C-O bond. In comparison, ␦ 11 is about 29°off the C=O bond for the non-Ptcoordinated oxygen. For both types of oxygen atoms, ␦ 33 is always perpendicular to the O=C-O plane. These tensor orientations are in general agreement with the previous results on carboxylates. 2 It is especially worth noting that the 17 O NMR tensor orientations found in carboplatin and oxaliplatin are very similar to those in ␣-oxalic acid dihydrate determined from a single-crystal 17 O NMR study 23 (see Fig. 3 
). This similarity suggests that the O-Pt coordination bond in O=C-O-Pt resembles the O-H covalent bond in O=C-O-H (vide infra).
It is also worth commenting on the sign change in C Q noted earlier. Since the definition of C Q is associated with the largest QC component (in its absolute value), the apparent sign change from 8.15 MHz for the non-Pt-coordinated oxygen to −6.50 MHz for the directly Pt-bonded oxygen does not mean that the net change in C Q is 8.15-(−6.50) = 14.65 MHz. Rather, one must examine the individual 17 O QC tensor components using the respective C-O bond as the frame of reference. As seen from 
A survey of 17 O coordination shifts from carboxylate-metal interactions
As mentioned in the previous section, the most interesting result in this study is the 200 ppm difference in ␦ iso ( 17 O) between the directly Pt-bonded and non-Pt-coordinated oxygen atoms. To put this in perspective, we surveyed the solid-state 17 O NMR data in the literature for metal-carboxylate interactions. To make direct comparison of NMR data from different compounds meaningful, we focused only on those carboxylates that exhibit the monodentate mode of binding to the metal ion, i.e., O=C-O-M +n . To aid discussion, we define an 17 O coordination shift (⌬) as ⌬ = ␦ iso (C-O-M +n ) -␦ iso (O=C). As illustrated in Fig. 4 , for alkali metals, M + , ⌬ is typically −20 ppm. For example, Wong et al. 31 reported the 17 O chemical shifts for the bound and noncoordinated oxygens in lithium ␤-oxalate are −249.6 and −265.0 ppm, respectively. For Mg(II)-and Al(III)-carboxylate interactions, Zhu and Wu observed that the 17 O coordination shifts are on the order of −50 and −60 ppm, respectively. 58 To make the comparison complete, Fig. 4 also shows that the chemical shift difference found in free carboxylic acid (O=C-O-H) where the "chelating" oxygen atom actually forms a covalent bond with H. In this case, the corresponding 17 O chemical shift difference is typically −150 ppm. In this context, the observed 17 O coordination shift of −200 ppm in carboplatin and oxaliplatin is quite remarkable and deserves further investigation as presented in the next section. We should also note that large negative 17 O coordination shifts have been previously reported in several solution 17 O NMR studies for oxygen-containing ligands bound to transition metals. [59] [60] [61] [62] [63] For example, Laurenczy et al. 52 observed that the 17 
The origin of 17 O coordination shifts
To better understand the very large 17 O coordination shift, we decided to carefully examine the 17 O NMR tensors. To aid discussion, we label the tensor components according to their directions with respect to the carboxylate plane. As shown in Fig. 5 , the in-plane tensor components parallel and perpendicular to the C-O bond are denoted as ʈ and Ќ, respectively, while the tensor component perpendicular to the O-C-O-Pt plane is defined as . Figure 5 illustrates the changes in tensor components between the two types of oxygen atoms. This analysis immediately reveals that while all three components of the 17 O QC tensors change considerably upon Pt coordination, the change in the ʈ component of the 17 O CS tensor is significantly larger than those in the other two components. Furthermore, because of the large change in the ʈ component, the orientations of the ␦ 11 and ␦ 22 components in the molecular frame of reference appear switched between the directly bonded and non-Pt-coordinated oxygen atoms. As a result, a "cross-over" effect is seen in Fig. 5 . A similar "␦ 11 -␦ 22 crossover" effect was previously reported for the phenolic oxygen atom of tyrosine between the protonated and deprotonated states. 64 To further identify the origin of the observed 17 O coordination shift in terms of specific molecular orbitals (MOs), we performed a detailed magnetic shielding analysis using the ADF program. 46 According to the Ramsey formalism of nuclear magnetic shielding, 65 the total magnetic shielding at a nucleus can be divided into diamagnetic and paramagnetic contributions:
In general, the diamagnetic shielding term is dominated by core electrons and consequently exhibits essentially no orientation dependence. In contrast, the paramagnetic shielding contribution is responsible for the anisotropic nature of the magnetic shielding tensor. In the formulation implemented in the ADF software package, p is further partitioned into three different parts: 46
where p (gauge), p (occ-occ), and p (occ-vir) denote the paramagnetic shielding contributions from the gauge, magnetic coupling among occupied MOs, and magnetic coupling between occupied and virtual MOs, respectively. 56, 57, 64, 67 that the high-lying nonbonding orbitals (electron lone pairs) on the oxygen atom often make the largest paramagnetic shielding contribution. Use oxaliplatin as an example. As seen in Fig. 6 , MO#92 and #93(HOMO) are largely localized on the non-Pt-coordinated oxygen atoms, each having a similar shape as a pure 2p atomic orbital perpendicular to the C-O bond. The ADF analysis showed that the magnetic coupling between these two MOs and all virtual MOs contributes −204 and −48 ppm of paramagnetic shielding for the non-Pt-coordinated and directly Ptbonded oxygen atoms, respectively (see Table 2 ). We also found that the magnetic coupling between MO#84 and #85 and all virtual MOs makes comparable paramagnetic shielding contributions on both types of oxygen atoms. Among the virtual MOs, the most important ones are of the * type such as MO#97 and #114, which can be magnetically coupled with MO#84, #85, #92, and #93 when the magnetic field lies along the ʈ direction, as also shown in Fig. 6 . So the above discussion has shown quite clearly that the large 17 O coordination shift observed in the Pt-carboxylate complexes is due to the significantly reduced paramagnetic shielding contribution on the directly Pt-bonded oxygen atom when the magnetic field is along the ʈ direction, which couples MO#92 and #93 with all virtual MOs with the right symmetry.
Conclusions
We have synthesized two 17 O-labled platinum-carboxylate complexes (carboplatin and oxaliplatin) that are well-known antican- cer drugs and carried out solid-state 17 O NMR experiments to determine the complete 17 O CS and QC tensors in these compounds. We found that the 17 O CS and QC tensors for the 2 oxygen atoms within the same carboxylate group are very different, reflecting the monodentate mode of binding between the carboxylate group and Pt(II), i.e., O=C-O-Pt. The observed large coordination shifts of 200 ppm in carboplatin and oxaliplatin are the largest reported to date in 17 O NMR studies. By examining the tensor orientations in the molecular frame of reference, we have determined the origin of such large 17 O coordination shifts in these Pt-carboxylate complexes. This is a good example to illustrate that 17 
Supporting information
Supplementary data are available with the article through the journal Web site at http://nrcresearchpress.com/doi/suppl/10.1139/ cjc-2015-0019.
